Selective serotonin-reuptake inhibitors (SSRIs) such as Paxil, Prozac, and Zoloft have been the darlings of the antidepressant market for years. New triple reuptake inhibitors (TRIs), which act on serotonin, dopamine, and norepinephrine, may replace SSRIs as the drug of choice.
Read moreI have heard women complain that when they take Prozac, the plus side is that they often lose their appetite and drop some weight. The... Read more »
In part one of this series on weight gain and antidepressants we talked about which medications are most likely to make you gain weight. ... Read more »
The Food and Drug Administration (FDA) issued a public health advisory (July, 2006) about potential risks of taking triptans together with... Read more »
Medical therapy to induce a castration is generally intended for use in patients who have advanced disease not curable by surgery,... Read more »
Breast Cancer News Editor's Note: Science and health news outlet EurekAlert! published yesterday an interesting summary of a Lancet study ... Read more »
An animal study has shown that a new class of antidepressants dramatically cut the time needed for the medications to take effect. Most currently... Read more »
There are a number of different medications that are currently used to treat anxiety disorders. Antidepressants, although originally intended to... Read more »
Scientists at MIT have developed a new type of magnetic resonance imaging (MRI) sensor that can track the movement of dopamine in the brain. The... Read more »
Over-the-counter non-steroidal anti-inflammatory drugs such as aspirin, ibuprofen, and naproxen may reduce the effectiveness of selective serotonin... Read more »